Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
Yuping Xia(Regeneron (United States)), John S. Rudge(MedStar Washington Hospital Center), Donna Hylton(Regeneron (United States)), Michael Detmar(ETH Zurich), George D. Yancopoulos(Regeneron (United States)), Baosheng Li(Shandong University)
Cited by 367
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Evinacumab for Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2020|763